HK/China Equity Long-Short

Osbert Tang, CFA

Osbert Tang is an equity analyst with over 20 years of experience with focuses on China transport, infrastructure, industrials and utilities sectors. He has been based in Shanghai since 2003, accumulated nearly 20 years of on-ground knowledge on the Chinese economy and financial markets, and has a wealth of contacts with China corporates and government entities. 

Osbert has received votes from top-tier institutional investors and has been a highly-ranked transport and infrastructure analyst in the Asiamoney, Institutional Investors and Greenwich surveys. In addition to his extensive experience with international investment banks including RBS, ABN AMRO (both served as Shanghai Chief Representative), Paribas Asia Equity, Maybank Kim Eng and DBS Securities, he has been a senior analyst with Moody’s Investors Service with focus on ratings of China infrastructure and related LGFV issuers. He has also worked in the area of strategic development at Sun Hung Kai Properties Limited. 

Osbert holds a BBA from the Chinese University of Hong Kong, an MBA from the University of Texas at Austin and a MSSc in Applied Psychology from the City University of Hong Kong. He was accredited with the CFA charter in 1997, and is a member of both British Psychological Society and Hong Kong Psychological Society.

HK Strategy: Finding the Gems in 1H25 HK IPOs

HK Strategy: Time to Revisit the Yield Story

China & HK Strategy: 1H25 Preview - Where Are the Upside and Downside Surprises?

HK & China Strategy: Potential Gainers of Rmb Appreciation Against USD

HK Strategy: Trend of Narrowing H-A IPO Discount

"Buy the Worst" HSI Strategy: Solid Gains in 1H25

Thematic (Sector/Industry)

Hong kong Industrials / Thematic (Sector/Industry)

<ul>
<li>YTD, the share prices of the H-share IPOs of A-shares increased by an average of 30.2%, and the H-A discount narrowed by 14.8pp, but the range is wide.</li>
<li>The growth outlook, as reflected by the 3-year EPS CAGR, is the key driver for the performance and reduction in H-A share discounts.</li>
<li>Market cap, absolute PER multiples, and even relative PER ratios are not the major factors supporting their post-IPO performance.</li>
</ul>


YTD, the share prices of the H-share IPOs of A-shares increased by an average of 30.2%, and the H-A discount narrowed by 14.8pp, but the range is wide.
The growth outlook, as reflected by the 3-year EPS CAGR, is the key driver for the performance and reduction in H-A share discounts.
Market cap, absolute PER multiples, and even relative PER ratios are not the major factors supporting their post-IPO performance.


Xiamen Yan Palace Bioengineering (XIAMEN HK)

Jiangsu Hengrui Pharmaceuticals (1276 HK)

Foshan Haitian Flavouring & Food Company (3288 HK)

Contemporary Amperex Technology (CATL) (3750 HK)

Hainan Drinda New Energy Technology (2865 HK)

Zhejiang Sanhua Intelligent Controls (2050 HK)

HK Strategy: How to Play the Future H IPOs of the As